Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US6949571 | EISAI INC | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
Jun, 2024
(2 months from now) | |
US8772497 | EISAI INC | Method for producing 1, 2-dihydropyridine-2-one compound |
Jul, 2026
(2 years from now) |
Market Authorisation Date: 29 April, 2016
Treatment: Treatment of primary generalized tonic-clonic seizures as adjunctive therapy in patients with epilepsy 12 years of age and older; Treatment of partial-onset seizures with or without secondarily genera...
Dosage: SUSPENSION;ORAL